Vaso.Pk

VASO.PK maintains a strong liquidity position, with $35.05 million in cash and equivalents, representing 39.67% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with a free cash flow of $1.5 million and total liabilities of $58.92 million, indicating a low liquidity risk. The current ratio of 1.59 suggests the company can cover its short-term obligations with its current assets.

Profitability metrics show mixed performance. The company reported a net income of $1.57 million on $89.1 million in revenue, yielding a net margin of 1.76%. However, it posted an operating loss of $2.06 million, indicating operational inefficiencies or high costs. Return on equity (ROE) of 5.33% and return on assets (ROA) of 1.78% are below the industry median for ROE and ROA in the Advanced Medical Equipment & Technology sector, suggesting underperformance relative to peers.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic or regulatory shifts. No material revenue concentration by geography is reported, but the absence of segmental or geographic breakdowns limits visibility into risk distribution.

Growth trajectory is constrained by the current operating loss and modest free cash flow. The company's capital expenditure of $925,000 reflects ongoing investment in operations, but the lack of revenue growth or margin expansion suggests limited near-term upside. No significant revenue growth is forecasted for the current or next fiscal year, with operating income remaining negative.

Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company has a low debt-to-equity ratio of 0.01, indicating minimal leverage risk. No dilution sources were identified in recent filings, and the diluted shares outstanding are equal to the basic shares, suggesting no near-term dilution pressure.

Recent events include the latest financial filing (market data), which shows a net income of $1.57 million despite an operating loss. No material events or earnings call transcripts were disclosed in the available data.